Is metformin a therapeutic paradigm for colorectal cancer: Insight into the molecular pathway?
Colorectal cancer (CRC) remains one of the major leading causes of cancer related morbidity and mortality. Apart from the conventional anti-neoplastic agents, metformin, a biguanide anti-diabetic agent, has recently found to have anti-cancer property. Several studies observed the effect of metformin...
出版年: | Current Drug Targets |
---|---|
第一著者: | 2-s2.0-85019587803 |
フォーマット: | Review |
言語: | English |
出版事項: |
Bentham Science Publishers B.V.
2017
|
オンライン・アクセス: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019587803&doi=10.2174%2f1389450118666161205125548&partnerID=40&md5=6a171daf9f53a3276a14e415d6366131 |
類似資料
-
Detrimental Impacts of High-Fat Diet on Colorectal Cancer Development: An Update on Molecular Mechanisms
著者:: Ponnusamy, 等
出版事項: (2025) -
Decoding the Methylation Patterns of ABC Transporters in Colorectal Cancer
著者:: 2-s2.0-85207909756
出版事項: (2024) -
Metabolites profile of colorectal cancer cells at different stages
著者:: Yusof H.M.; Ab-Rahim S.; Ngah W.Z.W.; Nathan S.; Jamal A R.A.; Mazlan M.
出版事項: (2019) -
Engineered liposomes mediated approach for targeted colorectal cancer drug Delivery: A review
著者:: 2-s2.0-85181882337
出版事項: (2024) -
Metabolomic characterization of colorectal cancer cell lines highlighting stage-specific alterations during cancer progression
著者:: Yusof H.M.; Ab-Rahim S.; Wan Ngah W.Z.; Nathan S.; Jamal A.A.R.; Mazlan M.
出版事項: (2021)